PMID- 31231363 OWN - NLM STAT- MEDLINE DCOM- 20200817 LR - 20200817 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 10 DP - 2019 TI - Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against Mycobacterium tuberculosis. PG - 1142 LID - 10.3389/fimmu.2019.01142 [doi] LID - 1142 AB - Gut microbial components serve as ligand for various pattern recognition receptors (PRRs) present on immune cells and thereby regulates host immunity. Dendritic cells (DCs) are highly specialized innate cells involved in immune response to Mycobacterium tuberculosis (Mtb) infection. The gut-lung axis is a potential therapeutic target in tuberculosis; however, understanding of the innate immune mechanism underlying the interaction of gut microbiota and lung still remains obscure. We investigated if antibiotics (Abx) induced gut dysbiosis is able to affect the activation of innate receptor, macrophage inducible C-type lectin (mincle) in lungs during Mtb infection. We found that dysbiosis reduced the lung mincle expression with a concomitant increase in Mtb survival. Further, Abx diminished the effector and memory T cell population, while elevating frequency of regulatory T cells (Tregs) in the lungs. Here, we show that dysbiotic mice exhibited low mincle expression on lung DCs. These DCs with impaired phenotype and functions had reduced ability to activate naive CD4 T cells, and thus unable to restrict Mtb survival. In vivo administration of trehalose-6,6-dibehenate (TDB: mincle ligand) efficiently rescued this immune defect by enhancing lung DCs function and subsequent T cell response. Further, gut microbial profiling revealed augmentation of Lactobacillus upon mincle stimulation in microbiota depleted animals. Accordingly, supplementation with Lactobacillus restored mincle expression on lung DCs along with anti-Mtb response. Our data demonstrate that gut microbiota is crucial to maintain DC-dependent lung immune response against Mtb, mediated by mincle. Abx interrupt this process to induce impaired T cell-response and increased susceptibility to Mtb. FAU - Negi, Shikha AU - Negi S AD - Immunology Division, CSIR-Institute of Microbial Technology, Chandigarh, India. FAU - Pahari, Susanta AU - Pahari S AD - Immunology Division, CSIR-Institute of Microbial Technology, Chandigarh, India. AD - Immunology Division, Texas Biomedical Research Institute, San Antonio, TX, United States. FAU - Bashir, Hilal AU - Bashir H AD - Immunology Division, CSIR-Institute of Microbial Technology, Chandigarh, India. FAU - Agrewala, Javed N AU - Agrewala JN AD - Immunology Division, CSIR-Institute of Microbial Technology, Chandigarh, India. AD - Center for Biomedical Engineering, Indian Institute of Technology, Rupnagar, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190528 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Anti-Bacterial Agents) RN - 0 (Clecsf8 protein, mouse) RN - 0 (Glycolipids) RN - 0 (Lectins, C-Type) RN - 0 (Membrane Proteins) RN - 0 (Receptors, Pattern Recognition) RN - 0 (trehalose 6,6'-dibehenate) SB - IM MH - Animals MH - Anti-Bacterial Agents/administration & dosage/pharmacology MH - CD4-Positive T-Lymphocytes/immunology/metabolism MH - Dendritic Cells/*immunology MH - Dysbiosis/drug therapy/immunology/microbiology MH - Gastrointestinal Microbiome/*immunology MH - Glycolipids/administration & dosage/pharmacology MH - Immunity, Innate/drug effects/immunology MH - Lactobacillus/immunology/physiology MH - Lectins, C-Type/genetics/*immunology/metabolism MH - Lung/*immunology MH - Macrophages/immunology/metabolism MH - Membrane Proteins/genetics/*immunology/metabolism MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mycobacterium tuberculosis/*immunology/physiology MH - Receptors, Pattern Recognition/immunology/metabolism MH - Tuberculosis/drug therapy/*immunology/microbiology PMC - PMC6558411 OTO - NOTNLM OT - T cells OT - antibiotics OT - gut-lung axis OT - lung dendritic cells OT - mincle OT - tuberculosis EDAT- 2019/06/25 06:00 MHDA- 2020/08/18 06:00 PMCR- 2019/01/01 CRDT- 2019/06/25 06:00 PHST- 2018/11/21 00:00 [received] PHST- 2019/05/07 00:00 [accepted] PHST- 2019/06/25 06:00 [entrez] PHST- 2019/06/25 06:00 [pubmed] PHST- 2020/08/18 06:00 [medline] PHST- 2019/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2019.01142 [doi] PST - epublish SO - Front Immunol. 2019 May 28;10:1142. doi: 10.3389/fimmu.2019.01142. eCollection 2019.